Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Zydus Pharmaceuticals (USA) Inc recalls Bromocriptine Mesylate Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.
Products
  • Bromocriptine Mesylate Capsules
Where it was sold

Nationwide in the USA

Nationwide

Units affected
36,624 bottles
About this recall
Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals, Pennington, NJ 08534. NDC 68382-110-06